ArticlePain reports2025
Narrative review of the scientific and methodological explanations for 101 mechanisms of opioid tolerance.
Article in Pain reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Repeated Tetrahydrocannabinol Injections Induce Tolerance but Do Not Disrupt Ongoing Behaviour Upon Withdrawal in Male and Female Rats With Inflammatory Pain.European journal of pain (London, England) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Opioids such as morphine and fentanyl are widely prescribed treatments for pain. Unfortunately, opioid use is limited by side effects, dependence, and the development of tolerance with repeated use. A major goal of preclinical opioid research is to identify the neural mechanisms underlying tolerance to opioids to provide better pain management and reduce side effects caused by high opioid doses. To that end, preclinical pain researchers have reported well over 101 mechanisms of opioid tolerance. The objective of this review is to describe both the scientific explanations for multiple mechanisms of opioid tolerance (eg, different types of opioid tolerance, different mechanisms at different locations and for different opioids) and the methodological problems that cause false positives. For example, many changes correlate with but do not cause tolerance. Opioid binding to mu-opioid receptors (MOR) activates a signaling cascade that includes numerous molecules and cells making it difficult to identify the precise mechanism causing tolerance. Other problems, such as lack of appropriate control groups or confounds produced by antinociceptive or motor effects of the treatment, are surprisingly common. Solutions to these problems are presented at the end of the article in the hope of guiding future research. Although the focus is on opioid tolerance, the problems and solutions presented here apply to tolerance to other drugs and any neural change that occurs over time such as learning.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.